Evidence map›Paper›PMID 33339003›Full record

ArticleEcho research and practice2020

Echocardiographic assessment of the tricuspid and pulmonary valves: a practical guideline from the British Society of Echocardiography.

Abbas Zaidi, David Oxborough, Daniel X Augustine, Radwa Bedair, Allan Harkness, Bushra Rana, Shaun Robinson, Luigi P Badano

Open access · goldAbstract read
In one paragraph

Article in Echo research and practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Continuous-wave Doppler interrogation in valvular heart disease: pearls and pitfalls.European heart journal. Imaging methods and practice · 2026
    Review
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 2 countries.

Abbas ZaidiUniversity Hospital of Wales, Cardiff, UK.
David OxboroughLiverpool John Moores University, Research Institute for Sports and Exercise Science, Liverpool, UK.
Daniel X AugustineRoyal United Hospitals Bath NHS Foundation Trust, Bath, UK.
Radwa BedairBristol Heart Institute, Bristol Royal Infirmary, Bristol, UK.
Allan HarknessEast Suffolk and North Essex NHS Foundation Trust, Essex, UK.
Bushra RanaImperial College Healthcare NHS Trust, London, UK.
Shaun RobinsonNorth West Anglia NHS Foundation Trust, Peterborough, UK.
Luigi P BadanoIstituto Auxologico Italiano, IRCCS, San Luca Hospital, Milan, Italy.
Bristol Royal Infirmary · GBEast Suffolk and North Essex NHS Foundation Trust · GBImperial College Healthcare NHS Trust · GBIstituti di Ricovero e Cura a Carattere Scientifico · ITLiverpool Heart and Chest Hospital · GBPeterborough City Hospital · GBUniversity Hospital of Wales · GBUniversity of Bath · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transthoracic echocardiography is the first-line imaging modality in the assessment of right-sided valve disease. The principle objectives of the echocardiographic study are to determine the aetiology, mechanism and severity of valvular dysfunction, as well as consequences on right heart remodelling and estimations of pulmonary artery pressure. Echocardiographic data must be integrated with symptoms, to inform optimal timing and technique of interventions. The most common tricuspid valve abnormality is regurgitation secondary to annular dilatation in the context of atrial fibrillation or left-sided heart disease. Significant pulmonary valve disease is most commonly seen in congenital heart abnormalities. The aetiology and mechanism of tricuspid and pulmonary valve disease can usually be identified by 2D assessment of leaflet morphology and motion. Colour flow and spectral Doppler are required for assessment of severity, which must integrate data from multiple imaging planes and modalities. Transoesophageal echo is used when transthoracic data is incomplete, although the anterior position of the right heart means that transthoracic imaging is often superior. Three-dimensional echocardiography is a pivotal tool for accurate quantification of right ventricular volumes and regurgitant lesion severity, anatomical characterisation of valve morphology and remodelling pattern, and procedural guidance for catheter-based interventions. Exercise echocardiography may be used to elucidate symptom status and demonstrate functional reserve. Cardiac magnetic resonance and CT should be considered for complimentary data including right ventricular volume quantification, and precise cardiac and extracardiac anatomy. This British Society of Echocardiography guideline aims to give practical advice on the standardised acquisition and interpretation of echocardiographic data relating to the pulmonary and tricuspid valves.

Indexed as

echocardiographyguidelinepulmonary valvetricuspid valve

Identifiers

PMID33339003
PMCPMC8052586
OpenAlexW3114899178

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.